Wednesday, July 22 Company Company Presentations 2–Biotech
Name /AnnJi Pharmaceutical Co. Ltd.(安基)
Address /B405, No. 18, Siyuan St., Zhongzhgng District, Taipei, Taiwan
Name /Karen Lin
Title /Senior Manager
Telephone /(Work) (886)223655677 ext 300
AnnJi Pharmaceutical Co. Ltd. (AnnJi) is specialized in target-based discovery, translation and early development of novel, druggable small-molecules. We focus on first-in-class and/or best-in-class drug candidates for diseases and conditions of high unmet-needs; such as, selective histone deacetylase (HDAC) inhibitors for neuropathic pain and fibrosis, and phosphodiesterase (PDE) inhibitors for the treatment of inflammatory diseases. AnnJi aims to develop innovative therapies for the global market, and aspires to be Taiwan’s leading drug developer in dermatology and neurology.
AnnJi has expertise spanning from lead generation to early clinical development. Novel compound leads are rationally designed through structural insight of selected protein targets and their key role(s) in disease pathophysiology; followed by lead optimization for drug likeness (structure activity relationship), the selection of preclinical drug candidates via rigorous in vitro, in vivo proof-of-concept investigations, and taken into first-in-human trial. The team at AnnJi has produced a pipeline of highly differentiated lead molecules that have superior safety profile, pharmacological activities, and therapeutic window compared to the current treatment regimen or investigational candidates in clinic. Our leading HDAC6 selective inhibitor for chemotherapy-induced peripheral neuropathy and difficult-to-treat fibrotic conditions such as idiopathic pulmonary fibrosis and cystic kidney disease will enter clinical phase in 2021, followed by the PDE4 specific inhibitor for psoriasis. In addition to compounds discovered organically, AnnJi is actively seeking opportunities to in-license and/or codevelop new drug in our focused therapeutic areas. The combination of our talented and specialized staffs, R&D pipeline, state-of-art research infrastructure, and a culture of integrity, compassion, teamwork that drives for excellence makes AnnJi a strong and unique team of choice to venture capitalists, biotech partners, and collaborators from academia and pharmaceutical companies.
Name /Karen Lin
Phone /(Work) (886)223655677 ext 300